Health Trials

Persistent Thrombocytopenia

1

Review clinical trials related to Persistent Thrombocytopenia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Baricitinib for Post-HSCT Persistent Thrombocytopenia

This is a prospective, open-label phase 1b/2 clinical trial to explore the safety and efficacy profiles of baricitinib in patients with thrombopoietin-receptor-agonist-refractory persistent thrombocytopenia after allogeneic hematopoietic stem cell transplantation.

Participants needed: 28
Trial details
Phase: Phase 1, Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Peking University People's HospitalUpdated: Apr 17, 2026Locations: 1
Eligibility criteria

Aged 18-70 years; [+5]

Relapse of hematologic malignancy or MRD positivity; [+13]

Read more